PureTech Health plc (LON:PRTC)
London · Delayed Price · Currency is GBP · Price in GBX 130.40
-0.80 (-0.61%)
Jun 16, 2026, 10:58 AM GMT
PureTech Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -109.74 | 53.51 | -65.7 | -50.35 | -60.56 |
Depreciation & Amortization | 3.35 | 3.57 | 4.93 | 8.89 | 7.29 |
Loss (Gain) From Sale of Assets | -0.09 | -151.79 | -61.47 | -27.11 | 0.05 |
Asset Writedown & Restructuring Costs | 0.11 | 0.23 | 1.26 | - | - |
Loss (Gain) From Sale of Investments | -36.93 | -11.08 | -50.05 | 41.53 | -158.39 |
Loss (Gain) on Equity Investments | 17.93 | 8.75 | 6.06 | 27.75 | 73.7 |
Stock-Based Compensation | 8.22 | 22.85 | 4.42 | 14.7 | 13.95 |
Other Operating Activities | 35.15 | -50.17 | 37.12 | -210.12 | -35.18 |
Change in Accounts Receivable | -0.24 | 0.63 | 9.75 | -7.73 | -0.62 |
Change in Accounts Payable | -1.03 | -9.7 | 3.84 | 22.03 | 8.34 |
Change in Unearned Revenue | - | - | -0.28 | 2.12 | -1.41 |
Change in Other Net Operating Assets | -1.86 | -1.17 | 4.21 | -0.5 | -5.45 |
Operating Cash Flow | -85.13 | -134.37 | -105.92 | -178.79 | -158.27 |
Capital Expenditures | -0.01 | -0.01 | -0.07 | -2.18 | -5.57 |
Sale of Property, Plant & Equipment | 0.27 | 0.26 | 0.87 | - | 0.03 |
Divestitures | - | -91.57 | -13.78 | -0.48 | - |
Sale (Purchase) of Intangibles | - | - | -0.18 | - | -0.09 |
Investment in Securities | 63.13 | 332.21 | 99.01 | -104.98 | 217.63 |
Other Investing Activities | -0.1 | - | -16.85 | 0.42 | -14.62 |
Investing Cash Flow | 63.29 | 240.89 | 68.99 | -107.22 | 197.38 |
Short-Term Debt Issued | - | - | - | 0.39 | 2.22 |
Total Debt Issued | - | - | - | 0.39 | 2.22 |
Long-Term Debt Repaid | -3.58 | -3.39 | -3.34 | -4.03 | -3.38 |
Net Debt Issued (Repaid) | -3.58 | -3.39 | -3.34 | -3.63 | -1.16 |
Issuance of Common Stock | 0.11 | 0.9 | 1.15 | 0.33 | 0.35 |
Repurchase of Common Stock | -2.85 | -107.56 | -19.65 | -26.49 | -13.33 |
Other Financing Activities | -0 | 93.1 | 99.98 | -0.04 | 36.87 |
Financing Cash Flow | -6.33 | -16.96 | 78.14 | -29.83 | 22.73 |
Miscellaneous Cash Flow Adjustments | - | -0 | - | - | -0 |
Net Cash Flow | -28.17 | 89.56 | 41.22 | -315.84 | 61.83 |
Free Cash Flow | -85.14 | -134.38 | -105.99 | -180.97 | -163.85 |
Free Cash Flow Margin | -1827.37% | -2783.35% | -3182.79% | -1158.71% | -942.29% |
Free Cash Flow Per Share | -0.35 | -0.53 | -0.38 | -0.64 | -0.57 |
Cash Interest Paid | 4.52 | 1.3 | 1.7 | 3.37 | 3.38 |
Cash Income Tax Paid | 5.5 | 37.91 | 0.15 | 20.7 | 27.77 |
Levered Free Cash Flow | -89.99 | -69.31 | -114.01 | -236.95 | -41.45 |
Unlevered Free Cash Flow | -61.38 | -63.03 | -105.58 | -234.48 | -38.51 |
Change in Working Capital | -3.12 | -10.24 | 17.52 | 15.92 | 0.86 |